Overview

Pharmacokinetic Study of Synera in Healthy Volunteers

Status:
Completed
Trial end date:
2010-03-01
Target enrollment:
Participant gender:
Summary
This study will measure the amount of lidocaine and tetracaine in the blood after 2-, 4-, and 12-hour application of 4 Synera patches and a 4 hour application of 4 patches without heat.
Phase:
Phase 1
Details
Lead Sponsor:
ZARS Pharma Inc.
Treatments:
Lidocaine
Tetracaine